reviewEndocrine ReviewsMar 29, 2005BRONZE OA

Noncalcemic Actions of Vitamin D Receptor Ligands

Eli Lilly (United States)

PubMed
Indexed incrossrefpubmed

Abstract

1alpha,25-Dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)], the active metabolite of vitamin D(3), is known for the maintenance of mineral homeostasis and normal skeletal architecture. However, apart from these traditional calcium-related actions, 1,25-(OH)(2)D(3) and its synthetic analogs are being increasingly recognized for their potent antiproliferative, prodifferentiative, and immunomodulatory activities. These actions of 1,25-(OH)(2)D(3) are mediated through vitamin D receptor (VDR), which belongs to the superfamily of steroid/thyroid hormone nuclear receptors. Physiological and pharmacological actions of 1,25-(OH)(2)D(3) in various systems, along with the detection of VDR in target cells, have indicated…

Citation impact

965
total citations
FWCI
27.58
Percentile
100%
References
314
Citations per year

Authors

3

Topics & keywords

Keywords
  • Calcitriol receptor
  • Medicine
  • Vitamin D and neurology
  • Internal medicine
  • Psoriasis
  • Cancer research
  • Secondary hyperparathyroidism
  • Endocrinology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.